Announcements

Intimation of decisions taken at the Board Meeting held on February 01, 2020, about (i) approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / nine months ended on 31-12-2019, (ii) deferring of further dividend to the next Meeting, (iii) reappointment of Dr. A. Velumani as Managing Director & Chief Executive Officer for a further period of five years, and (iv) reappointment of Mr. A. Sundararaju as Executive Director & Chief Financial Officer for a further period of five years.

Intimation about Board Meeting scheduled to be held on Saturday, February 01, 2020 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended December 31, 2019, payment of further interim dividend, if any, and reappointment of Dr. A. Velumani as Managing Director & CEO and Mr. A. Sundararaju as Executive Director & CFO.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st January 2020 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter /Nine months ended December 31, 2019.

Intimation that the Company has allotted 37,759 numbers of equity shares to 103 eligible employees of the Company, who have exercised the Options granted to them under ESOP Scheme 2016.

Intimation about meeting of representative(s) of Sundaram Asset Management Company Limited, with us at 10.30 A.M. on Saturday, December 14, 2019 at the Corporate Office of the Company.

Intimation about the following forthcoming Analyst meetings:

(i) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 11.30 A.M. on Monday, December 09, 2019.

(ii) Meeting with the representative(s) of PhillipCapital (India) Pvt. Ltd., at 03.30 P.M. on Wednesday, December 11, 2019.

(iii) Meeting with the representative(s) of Arisaig Partners, at 11.00 A.M. on Monday, December 16, 2019.

(iv) Meeting with the representative(s) of Spark Capital Advisors (I) Pvt. Ltd., at 11.00 A.M. on Tuesday, December 17, 2019, to be followed by a visit by them to our lab.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Nippon India Mutual Fund, at 04.00 P.M. on Tuesday, December 03, 2019.

(ii) Meeting with the representative(s) of ADD Capital, at 03.30 P.M. on Wednesday, December 04, 2019, at the Corporate Office of the Company.

Intimation about meeting of representative(s) of InvesQ Investment Advisors, with us at 11.00 A.M. on Friday, November 29, 2019 at the Corporate Office of the Company.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Eternity Capital Management Limited, at 11.30 A.M. on Monday, November 25, 2019.

(ii) Meeting with the representative(s) of Capital Investment Research Services Private Limited (Capital Group), at 10.30 A.M. on Monday, December 02, 2019, at the Corporate Office of the Company.

Intimation about the following forthcoming Con-call / Analyst meeting:

(i) Con-call with the representative(s) of Bajaj Allianz, Pune, at 04.00 P.M. on Thursday, November 21, 2019.

(ii) Meeting with the representative(s) of Vishuddha Capital Management, at 03.00 P.M. on Friday, November 22, 2019, at the Corporate Office of the Company.

Intimation of decisions taken at the Board Meeting held on November 07, 2019, about approval of the Unaudited Financial Results (both Stand-alone and Consolidated) for the quarter / half year ended on 30-09-2019 and declaration of interim dividend of Rs.5/- per share for FY 2019-20, and fixing of Friday, November 22, 2019 as the Record Date for this purpose.

Intimation about Board Meeting scheduled to be held on Thursday, November 07, 2019 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended September 30, 2019, and to consider payment of interim dividend, if any.

Intimation that  the representative(s) of Capital Investment Research Services Private Limited would be having a Con-call with us by 05.30 P.M. on Friday, October 04, 2019.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with effect from 1^st October 2019 and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter /Half-year ended September 30, 2019.

Intimation about the following forthcoming meeting / Con-call:

(i) Con-call with the representative(s) of Sundaram Asset Management Company Limited, at 10.30 A.M. on Monday, September 30, 2019.

(ii) Meeting with the representative(s) of Fundsmith LLP, at 2.30 P.M. on Tuesday, October 01, 2019.

At their meeting held today, the Audit Committee reviewed the valuation reports of Nueclear Healthcare Ltd., (NHL) received from Karvy Investor Services Ltd. and noted the long gestation period of this business in terms of returns. The Committee also felt that accepting the offer of Dr. A. Velumani, Chairman, MD & CEO, to acquire the entire shareholding in NHL may result in dilution of his focus and time, which is not in the interest of the Company. Hence, the Audit Committee recommended that it is not expedient to accept the offer of Dr. A. Velumani at this juncture.

The Board, which met subsequently, accepted the above recommendation of the Audit Committee.

None of the promoter-directors, were present during the discussions at the Audit Committee Meeting and at the meeting of the Board of Directors.

Intimation about Board Meeting scheduled to be held on Saturday, September 21, 2019 to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company’s shareholding in NHL or dispose it of.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Sunidhi Securities & Finance Limited, at 4.00 P.M. on Thursday, September 19, 2019.

(ii) Meeting with the representative(s) of India Ratings & Research (Fitch Group), at 4.00 P.M. on Friday, September 20, 2019.

Intimation that  the representative(s) of Angle Broking Limited would be having a Con-call with us by 11.00 A.M. on Monday, September 16, 2019.

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.30 A.M. on Tuesday, August 27, 2019 at the Corporate Office of the Company.

Intimation that Mr. Anand Velumani, Director, Nueclear Healthcare Limited, our wholly owned subsidiary, would be participating at the ‘15^th Annual Global Investor Conference’ organized by M/s. Motilal Oswal Financial Services Limited, at Hotel Grand Hyatt, Mumbai on 20^th August, 2019, where representatives of various fund houses would be meeting him.

Intimation about conference call for Indian and Overseas Investors to be held on 14-08-2019 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2019

Click here to see the invite

Intimation about the outcome of the Board Meeting held on 10-08-2019

(i) Approval of Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2019.

(ii) Approval of issue and allotment of new equity shares not exceeding 37,859 shares to those employees who may be exercising the Stock Options granted to them in 2016 and vesting on them on 12^th September 2019, subject to compliance with applicable regulations.

Intimation about Board Meeting scheduled to be held on Saturday, August 10, 2019 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter ended June 30, 2019.

Intimation about (i) 19th Annual General Meeting convened to be held on 24-08-2019 at 3.00 P.M. at Hotel Yogi Midtown, Turbhe , Navi Mumbai,

(ii) Book-Closure from 18-08-2019 to 24-08-2019 (both days inclusive) for payment of final dividend of Rs.20/- (on approval by shareholders), &

(iii) E-voting facility available to the Shareholders.

Intimation about meeting of representative(s) of Baring Private Equity Asia, with us at 3.30 P.M. on Friday, July 05, 2019, at the Corporate Office of the Company, followed by a visit to our Lab.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with immediate effect and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2019.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of PhillipCapital India Private Limited, at 3.30 P.M. on Wednesday, July 03, 2019.

(ii) Meeting with the representative(s) of Centrum Capital Ltd., at 4.30 P.M. on Friday, July 05, 2019.

Post-script of the conference call of Indian and Overseas Investors held on 21-05-2019 to discuss about audited financial results (stand-alone & consolidated) for the year ended 31-03-2019. Click here

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Securities Investment Management Pvt. Ltd., at 3.30 P.M. on Wednesday, June 26, 2019.

(ii) Meeting with the representative(s) of HDFC Securities Limited, at 4.30 P.M. on Wednesday, June 26, 2019.